Growth Metrics

GT Biopharma (GTBP) Goodwill & Intangibles (2017 - 2019)

GT Biopharma (GTBP) has disclosed Goodwill & Intangibles for 8 consecutive years, with $25.3 million as the latest value for Q2 2019.

  • On a quarterly basis, Goodwill & Intangibles fell 90.05% to $25.3 million in Q2 2019 year-over-year; TTM through Jun 2019 was $25.3 million, a 90.05% decrease, with the full-year FY2017 number at $253.8 million, changed N/A from a year prior.
  • Goodwill & Intangibles was $25.3 million for Q2 2019 at GT Biopharma, roughly flat from $25.3 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $253.8 million in Q3 2017 to a low of $25.3 million in Q1 2019.
  • A 3-year average of $155.8 million and a median of $253.8 million in 2017 define the central range for Goodwill & Intangibles.
  • Peak YoY movement for Goodwill & Intangibles: crashed 90.05% in 2018, then crashed 90.05% in 2019.
  • GT Biopharma's Goodwill & Intangibles stood at $253.8 million in 2017, then plummeted by 90.05% to $25.3 million in 2018, then decreased by 0.0% to $25.3 million in 2019.
  • Per Business Quant, the three most recent readings for GTBP's Goodwill & Intangibles are $25.3 million (Q2 2019), $25.3 million (Q1 2019), and $25.3 million (Q3 2018).